- Home
- TAYD vs ANVS Comparison
TAYD vs ANVS Comparison
Compare TAYD & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAYD
- ANVS
- Stock Information
- Founded
- TAYD 1955
- ANVS 2008
- Country
- TAYD United States
- ANVS United States
- Employees
- TAYD N/A
- ANVS N/A
- Industry
- TAYD Industrial Machinery/Components
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- TAYD Industrials
- ANVS Health Care
- Exchange
- TAYD Nasdaq
- ANVS Nasdaq
- Market Cap
- TAYD 104.2M
- ANVS 92.6M
- IPO Year
- TAYD N/A
- ANVS 2020
- Fundamental
- Price
- TAYD $32.43
- ANVS $2.13
- Analyst Decision
- TAYD
- ANVS Strong Buy
- Analyst Count
- TAYD 0
- ANVS 6
- Target Price
- TAYD N/A
- ANVS $31.40
- AVG Volume (30 Days)
- TAYD 20.0K
- ANVS 684.1K
- Earning Date
- TAYD 03-27-2025
- ANVS 03-31-2025
- Dividend Yield
- TAYD N/A
- ANVS N/A
- EPS Growth
- TAYD 27.48
- ANVS N/A
- EPS
- TAYD 2.70
- ANVS N/A
- Revenue
- TAYD $44,486,041.00
- ANVS N/A
- Revenue This Year
- TAYD N/A
- ANVS N/A
- Revenue Next Year
- TAYD N/A
- ANVS N/A
- P/E Ratio
- TAYD $12.00
- ANVS N/A
- Revenue Growth
- TAYD 8.83
- ANVS N/A
- 52 Week Low
- TAYD $31.30
- ANVS $2.08
- 52 Week High
- TAYD $64.50
- ANVS $20.00
- Technical
- Relative Strength Index (RSI)
- TAYD 41.80
- ANVS 18.43
- Support Level
- TAYD $31.30
- ANVS $2.08
- Resistance Level
- TAYD $32.50
- ANVS $2.79
- Average True Range (ATR)
- TAYD 0.96
- ANVS 0.32
- MACD
- TAYD 0.23
- ANVS -0.06
- Stochastic Oscillator
- TAYD 48.29
- ANVS 2.08
About TAYD Taylor Devices Inc.
Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.